In an interview published by the Cambridge Core on behalf of the Society for Healthcare Epidemiology of America, OHT’s Dr. Ramanan Laxminarayan says, “I am optimistic that 20 years from now, we will have addressed this (antimicrobial resistance) in a significant way through a combination of tools, and we’ll look back and say that there was a period when antimicrobial resistance (AMR) was bad, but now things are far better. I think we’ve seen this kind of despair followed by progress with HIV, malaria, and other infectious diseases, including with COVID. But the darkest hour comes before the dawn. I hope we are in that darkest hour with AMR right now and that dawn is not far away.”

Find the interview here.